FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045307631> ?p ?o ?g. }

• W2045307631 endingPage "777" @default.
• W2045307631 startingPage "777" @default.
• W2045307631 abstract "Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B Daniel Chao, Ke-Qin HuDivision of Gastroenterology and Hepatology, University of California, Irvine Medical Center, Orange, CA, USAAbstract: Chronic hepatitis B continues to be a global problem, with an estimated 240 million cases according to the World Health Organization. Chronic infection with the hepatitis B virus (HBV) is associated with cirrhosis, hepatic decompensation, and hepatocellular carcinoma. There are currently several US Food and Drug Administration-approved medications for treating chronic hepatitis B, with Lamivudine (LAM) being the first oral agent made available. The major problem with LAM is significantly decreased effectiveness over time due to the development of anti-HBV resistance that can lead to virologic and biochemical breakthrough as well as hepatitis B flare, progression of liver disease, and decompensation of pre-existing cirrhosis. Despite its high anti-HBV resistant rate, LAM remains widely used in underdeveloped countries due to its wide availability and low cost compared to other antiviral medications, including those that are more effective. Therefore, it is still clinically important to learn how to prevent and treat LAM resistant strains of HBV. Several regimens with the other available antiviral agents have been studied, including switching to monotherapy with either Adefovir, Entecavir, or Tenofovir, adding Adefovir to LAM, and switching to a combination of Adefovir and Entecavir. This review article will examine molecular mechanisms and diagnosis of LAM anti-HBV resistance, risks for and approaches to reduce LAM anti-HBV resistance, and currently available rescue therapy regimens for LAM resistance.Keywords: chronic hepatitis B, nucleot(s)ide analogues, anti-viral resistance, lamivudine, adefovir, entecavir, tenofovir" @default.
• W2045307631 created "2016-06-24" @default.
• W2045307631 creator A5053853521 @default.
• W2045307631 creator A5085116941 @default.
• W2045307631 date "2013-08-01" @default.
• W2045307631 modified "2023-10-18" @default.
• W2045307631 title "Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B" @default.
• W2045307631 cites W133318803 @default.
• W2045307631 cites W1513593427 @default.
• W2045307631 cites W1538580578 @default.
• W2045307631 cites W1540959081 @default.
• W2045307631 cites W1563373589 @default.
• W2045307631 cites W1594567624 @default.
• W2045307631 cites W1871526758 @default.
• W2045307631 cites W1964242359 @default.
• W2045307631 cites W1976104517 @default.
• W2045307631 cites W1983218872 @default.
• W2045307631 cites W1983856314 @default.
• W2045307631 cites W1985577568 @default.
• W2045307631 cites W1985860298 @default.
• W2045307631 cites W2003804222 @default.
• W2045307631 cites W2008750754 @default.
• W2045307631 cites W2009944703 @default.
• W2045307631 cites W2010843828 @default.
• W2045307631 cites W2012062617 @default.
• W2045307631 cites W2012138074 @default.
• W2045307631 cites W2017039225 @default.
• W2045307631 cites W2021668727 @default.
• W2045307631 cites W2027543203 @default.
• W2045307631 cites W2040289109 @default.
• W2045307631 cites W2040489739 @default.
• W2045307631 cites W2042033552 @default.
• W2045307631 cites W2046973850 @default.
• W2045307631 cites W2050081098 @default.
• W2045307631 cites W2051976356 @default.
• W2045307631 cites W2053539344 @default.
• W2045307631 cites W2055270948 @default.
• W2045307631 cites W2058388169 @default.
• W2045307631 cites W2059173760 @default.
• W2045307631 cites W2059560167 @default.
• W2045307631 cites W2062207132 @default.
• W2045307631 cites W2070341160 @default.
• W2045307631 cites W2071555406 @default.
• W2045307631 cites W2076506726 @default.
• W2045307631 cites W2091287215 @default.
• W2045307631 cites W2094110283 @default.
• W2045307631 cites W2094756086 @default.
• W2045307631 cites W2095136337 @default.
• W2045307631 cites W2104427216 @default.
• W2045307631 cites W2108147025 @default.
• W2045307631 cites W2113135059 @default.
• W2045307631 cites W2119955306 @default.
• W2045307631 cites W2120403963 @default.
• W2045307631 cites W2126563189 @default.
• W2045307631 cites W2126656073 @default.
• W2045307631 cites W2138781119 @default.
• W2045307631 cites W2142557452 @default.
• W2045307631 cites W2143584498 @default.
• W2045307631 cites W2147133758 @default.
• W2045307631 cites W2148399664 @default.
• W2045307631 cites W2149457301 @default.
• W2045307631 cites W2158043516 @default.
• W2045307631 cites W2159303823 @default.
• W2045307631 cites W2338794667 @default.
• W2045307631 cites W2943463865 @default.
• W2045307631 cites W2146003334 @default.
• W2045307631 cites W2593633484 @default.
• W2045307631 doi "https://doi.org/10.2147/dddt.s33947" @default.
• W2045307631 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3753145" @default.
• W2045307631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23990707" @default.
• W2045307631 hasPublicationYear "2013" @default.
• W2045307631 type Work @default.
• W2045307631 sameAs 2045307631 @default.
• W2045307631 citedByCount "12" @default.
• W2045307631 countsByYear W20453076312014 @default.
• W2045307631 countsByYear W20453076312015 @default.
• W2045307631 countsByYear W20453076312016 @default.
• W2045307631 countsByYear W20453076312017 @default.
• W2045307631 countsByYear W20453076312018 @default.
• W2045307631 countsByYear W20453076312022 @default.
• W2045307631 crossrefType "journal-article" @default.
• W2045307631 hasAuthorship W2045307631A5053853521 @default.
• W2045307631 hasAuthorship W2045307631A5085116941 @default.
• W2045307631 hasBestOaLocation W20453076311 @default.
• W2045307631 hasConcept C126322002 @default.
• W2045307631 hasConcept C159047783 @default.
• W2045307631 hasConcept C2522874641 @default.
• W2045307631 hasConcept C2776175608 @default.
• W2045307631 hasConcept C2777214474 @default.
• W2045307631 hasConcept C2777382497 @default.
• W2045307631 hasConcept C2777869810 @default.
• W2045307631 hasConcept C2778019345 @default.
• W2045307631 hasConcept C2778721985 @default.
• W2045307631 hasConcept C2779517838 @default.
• W2045307631 hasConcept C2780593183 @default.
• W2045307631 hasConcept C41260117 @default.
• W2045307631 hasConcept C71924100 @default.
• W2045307631 hasConcept C90924648 @default.

• next